Literature DB >> 34192629

Prevalence of suicidal ideation and planning in patients with major depressive disorder: A meta-analysis of observation studies.

Hong Cai1, Yu Jin2, Shou Liu3, Qinge Zhang4, Ling Zhang4, Teris Cheung5, Lloyd Balbuena6, Yu-Tao Xiang7.   

Abstract

BACKGROUND: Suicidal ideation (SI) and suicide planning (SP) are associated with an increased risk of future suicide. We performed a meta-analysis of observational studies to estimate the prevalence of SI and SP in patients with major depressive disorder (MDD) and its associated factors.
METHODS: A systematic literature search was conducted in PubMed, EMBASE, PsycINFO and Web of Science from their commencement date until 7 October 2020. Original studies containing data on the prevalence of SI and SP in individuals with MDD were analyzed.
RESULTS: Forty-six articles covering 53,598 patients were included in the meta-analysis. The overall prevalence of SI was 37.7% (95% confidence interval (CI): 32.3-43.4%) and the pooled prevalence of SP was 15.1% (95% CI: 8.0--26.8%). Subgroup analyses revealed that the timeframe over which SI was assessed, source of patients, study design, and diagnostic criteria were significantly associated with the pooled prevalence of SI. Meta-regression analyses revealed that the Hamilton Depression Rating Scale (HAMD) score and percentage of male participants were positively associated with the pooled prevalence of SI. Study quality and mean age were negatively associated with the pooled prevalence of SI. In contrast, survey year and study quality were negatively associated with pooled prevalence of SP LIMITATION: SI and SP were self-reported and subject to recall bias and impression management.
CONCLUSIONS: SI and SP are common in patients with MDD, especially among inpatients. Preventive measures and treatments focusing on factors associated with SI and SP may reduce the risk of suicide in patients with MDD.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Major depressive disorder; Meta-analysis; Suicidal ideation; Suicide planning

Year:  2021        PMID: 34192629     DOI: 10.1016/j.jad.2021.05.115

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Asperosaponin VI ameliorates the CMS-induced depressive-like behaviors by inducing a neuroprotective microglial phenotype in hippocampus via PPAR-γ pathway.

Authors:  Xue Jiang; Saini Yi; Qin Liu; Dapeng Su; Liangyuan Li; Chenghong Xiao; Jinqiang Zhang
Journal:  J Neuroinflammation       Date:  2022-05-24       Impact factor: 9.587

2.  Plasma VEGF Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation.

Authors:  Wei Zheng; Li-Mei Gu; Yan-Ling Zhou; Cheng-Yu Wang; Xiao-Feng Lan; Bin Zhang; Yu-Ping Ning
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 5.435

3.  Factors associated with symptoms of major depression disorder among transgender women in Northeast Brazil.

Authors:  Marcelo Machado de Almeida; Luís Augusto Vasconcelos da Silva; Francisco Inácio Bastos; Mark Drew Crosland Guimarães; Carolina Coutinho; Ana Maria de Brito; Socorro Cavalcante; Inês Dourado
Journal:  PLoS One       Date:  2022-09-01       Impact factor: 3.752

4.  Prevalence of suicide in cocaine users accessing health services: a systematic review and meta-analysis.

Authors:  Milton Moçambique; Aline Hoffmann; Vinícius S Roglio; Felix H P Kessler; Carla Dalbosco; Jaqueline B Schuch; Flavio Pechansky
Journal:  Braz J Psychiatry       Date:  2022-06-24

5.  Serious Mental Illness Exacerbation Post-Bereavement: A Population-Based Study of Partners and Adult Children.

Authors:  Djin L Tay; Lau C Thygesen; Elissa Kozlov; Katherine A Ornstein
Journal:  Clin Epidemiol       Date:  2022-09-20       Impact factor: 5.814

6.  Prevalence of suicidality in clinically stable patients with major depressive disorder during the COVID-19 pandemic.

Authors:  Ling Zhang; Hong Cai; Wei Bai; Si-Yun Zou; Ke-Xin Feng; Yu-Chen Li; Huan-Zhong Liu; Xiangdong Du; Zhen-Tao Zeng; Chang-Mou Lu; Lan Zhang; Wen-Fang Mi; Yan-Hong Ding; Juan-Juan Yang; Todd Jackson; Teris Cheung; Zhaohui Su; Feng-Rong An; Yu-Tao Xiang
Journal:  J Affect Disord       Date:  2022-03-22       Impact factor: 6.533

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.